CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 2,396 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Business Operations gave up 1,964 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP, Quality & Ethics, and CPL acquired 96,310 shares (grant or award)
- 4 Grant or award EVP, Ext Aff, GC, Corp Sec acquired 56,180 shares (grant or award)
- 4 Open-market sale Director sold 1,912 shares at $11.94 ($22,829)
- 4 Shares withheld for taxes EVP, Ext Aff, GC, Corp Sec gave up 416 shares (to pay taxes)
- 4 Grant or award Director acquired 11,852 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 1,173 shares at $31.52 ($36,973)
- 4 Grant or award Director acquired 8,446 shares (grant or award)
- 4 Grant or award Director acquired 8,446 shares (grant or award)
- 4 Grant or award Director acquired 8,446 shares (grant or award)
- 4 Grant or award Director acquired 8,446 shares (grant or award)
- 4 Grant or award Director acquired 8,446 shares (grant or award)
- 4 Grant or award Director acquired 8,446 shares (grant or award)
- 4 Grant or award Director acquired 8,446 shares (grant or award)
- 4 Open-market sale Director sold 1,996 shares at $35.53 ($70,918)
- 4 Grant or award EVP, Quality & Ethics, and CPL acquired 11,826 shares (grant or award)
- 4 Grant or award Director acquired 8,595 shares (grant or award)
Page 10 of 49 · 970 filings